RGBOQ — ReGen Biologics Income Statement
0.000.00%
Last trade - 00:00
HealthcareHighly SpeculativeMicro Cap
R2004 December 31st | 2005 December 31st | 2006 December 31st | 2007 December 31st | 2008 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K/A | 10-K/A | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0.504 | 0.57 | 0.586 | 0.986 | 1.37 |
Cost of Revenue | |||||
Gross Profit | 0.123 | 0.002 | 0.08 | 0.521 | 0.681 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 7.71 | 12.4 | 13.1 | 11.3 | 10.5 |
Operating Profit | -7.21 | -11.9 | -12.6 | -10.3 | -9.14 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -7.2 | -11.7 | -12.7 | -10.4 | -9.95 |
Provision for Income Taxes | |||||
Net Income After Taxes | -7.2 | -11.7 | -12.7 | -10.4 | -9.95 |
Net Income Before Extraordinary Items | |||||
Net Income | -7.2 | -11.7 | -12.7 | -10.4 | -9.95 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | -7.96 | -11.9 | -12.8 | -10.7 | -12.7 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -3.75 | -3.95 | -3.58 | -2.07 | -2.41 |
Dividends per Share |